Posttraumatic stress disorder and depression in heart transplantation recipients: The relationship with outcome and adherence to medical treatment

General Hospital Psychiatry

Volumn 33, Issue 1, 2011, Pages 1-7

  Favaro, Angela ^a   Gerosa, Gino ^a   Caforio, Alida L P ^a   Volpe, Biancarosa ^b   Rupolo, Giampietro ^a   Zarneri, Deborah ^a   Boscolo, Silvia ^a   Pavan, Chiara ^a   Tenconi, Elena ^a   d'Agostino, Chiara ^a   Moz, Monica ^a   Torregrossa, Gianluca ^a   Feltrin, Giuseppe ^a   Gambino, Antonio ^a   Santonastaso, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Health Regional Council   (Italy)

Author keywords

Cancer; Compliance; Heart transplantation; Major depression; Mortality; PTSD

Indexed keywords

ANTIDEPRESSANT AGENT; AZATHIOPRINE; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PATIENT ATTITUDE; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PROSTATE CANCER; PSYCHOTHERAPY; RISK FACTOR; SKIN CANCER; SMOKING; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; STRUCTURED INTERVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; FORECASTING; HEART TRANSPLANTATION; HUMANS; INTERVIEW, PSYCHOLOGICAL; ITALY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PROSPECTIVE STUDIES; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 79951854097     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2010.10.001     Document Type: Article

References (32)

1. Zipfel S., Schneider A., Wild B., et al. Effect of depressive symptoms on survival after heart transplantation. Psychosom Med 2002, 64:740-747.
2. Owen J.E., Bonds C.L., Wellisch D.K. Psychiatric evaluations of heart transplant candidates: predicting post-transplant hospitalizations, rejection episodes, and survival. Psychosomatics 2006, 47:213-222.
3. Dew M.A., Kormos R.L., Roth L.H., Murali S., DiMartini A., Griffith B.P. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999, 18:549-562.
4. Havik O.E., Sivertsen B., Relbo A., et al. Depressive symptoms and all-cause mortality after heart transplantation. Transplantation 2007, 84:97-103.
5. Dobbels F., Vanhaecke J., Dupont L., et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation 2009, 87:1497-1504.
6. Frasure-Smith N., Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005, 67(Suppl 1):S19-25.
7. Carney R.M., Freedland K.E. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry 2009, 166:410-417.
8. Dew M.A., DiMartini A.F., De Vito Dabbs A., et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007, 83:858-873.
9. Skotzko C.E., Rudis R., Kobashigawa J.A., Laks H. Psychiatric disorders and outcome following cardiac transplantation. J Heart Lung Transplant 1999, 18:952-956.
10. Bunzel B., Laederach-Hofmann K. Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview. Transplantation 2000, 70:711-716.
11. Surman O.S., Cosimi A.B., DiMartini A. Psychiatric care of patients undergoing organ transplantation. Transplantation 2009, 87:1753-1761.
12. DiMatteo M.R. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004, 23:207-218.
13. Dew M.A., Roth L.H., Schulberg H.C., et al. Prevalence and predictors of depression and anxiety-related disorders during the year after heart transplantation. Gen Hosp Psychiatry 1996, 18:48S-61S.
14. Stukas A.A., Dew M.A., Switzer G.E., DiMartini A., Kormos R.L., Griffith B.P. PTSD in heart transplant recipients and their primary family caregivers. Psychosomatics 1999, 40:212-221.
15. Mintzer L.L., Stuber M.L., Seacord D., Castaneda M., Mesrkhani V., Glover D. Traumatic stress symptoms in adolescent organ transplant recipients. Pediatrics 2005, 115:1640-1644.
16. Oerlemans M.E.J., van den Akker M., Schuurman A.G., Kellen E., Buntinx F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health 2007, 3(29):1-11.
17. Chida Y., Hamer M., Wardle J., Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? A systematic quantitative review of 40 years of inquiry. Nat Clin Pract Oncol 2008, 5:466-475.
18. Taylor D.O., Stehlik J., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009. J Heart Lung Tranplant 2009, 28:1007-1022.
19. Caforio A.L., Fortina A.B., Piaserico S., et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000, 102(Suppl 3):222-227.
20. Caforio A.L.P., Tona F., Belloni Fortina A., et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 2004, 4:962-970.
21. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders 1995, Biometrics Research Department, New York.
22. Brown E.S., Suppes T. Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998, 5:239-246.
23. Dobbels F., Skeans M.A., Snyder J.J., Tuomari A.V., Maclean J.R., Kasiske B.L. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis 2008, 51:819-828.
24. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 2005, 5:243-251.
25. Reiche E.M., Nunes S.O., Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol 2004, 5:617-625.
26. Antoni M.H., Lutgendorf S.K., Cole S.W., et al. The influence of biobehavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006, 6:240-248.
27. Yang E., Glaser R. Stress-induced immunomodulation: implications for tumorigenesis. Brain Behav Immun 2003, 17:S37-S40.
28. Lawlor D.A., Juni P., Ebrahim S., Egger M. Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer. J Clin Epidemiol 2003, 56:155-163.
29. Serraino D., Piselli P., Busnach G., et al. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 2007, 43:2117-2123.
30. Prieto J.M., Atala J., Blanch J., et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 2005, 23:6063-6071.
31. Shemesh E., Yehuda R., Milo O., et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004, 66:521-526.
32. Schafer-Keller P., Steiger J., Bock A., Denhaerynck K., D Geest S. Diagnostic accuracy of measurement methods to assess non-adhrence to immunosuppressive drugs in kidney transplant recipients. Am J Transpl 2008, 8:616-626.